Metacon invest €1.5 million into Helbio and increase its shareholding

Helbio Holdings has carried out a share capital increase of €1.5 million. Metacon AB subscribed for the full amount of the placement and was granted full allocation. 

As a result, 8,452 new shares were issued at a subscription price of €177.47. Following the capital increase, Helbio Holdings capital is made up of 163,406 shares with a nominal value of €1 each, equating to a total share capital of €163,406. Metacon’s ownership in Helbio Holdings amounts to 58.87% post the new issuance of shares. Helbio Holdings S.A. owns 100% of Helbio S.A.

“We are pleased with the result of the rights issue, which will bolster R&D, production and product development as well as provide adequate resources for the imminent commercialization of our products.” says, Xenophon Verykios, CEO of Helbio.

For further information, please contact CEO Christopher Tornblom, phone +44 7827 509544 or e-mail info@metacon.se

This information is information that Metacon AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 15:10 CET on November 17, 2020.

About Metacon AB (publ)

Metacon AB (publ) is an international energy technology company. It offers patented technology for cost efficient and environmentally friendly production of hydrogen, through a catalyst process, for the transportation, industrial, commercial- and residential real estate sector.

Additional information may be found at https://metacon.se | Twitter: @Metaconab | LinkedIn: https://www.linkedin.com/company/metaconab
 

Metacon AB, Tomtebogatan 2, SE-703 43 Örebro, SWEDEN | Tfn: +46 586 740080 | E-post: info@metacon.se